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The chronic mild stress (CMS) model of depression is considered by many to be the animal model of
depression that has the greatest validity and translational potential, but it has often been criticized for a
perceived lack of reliability. The aims of this study were to establish the extent to which the procedure is
reproducible, and to identify experimental variables relevant to its reliability. Because failures to replicate
frequently remain unpublished, a survey methodology was used. A questionnaire was circulated to 170
labs identiﬁed from a PubMed search as having published a CMS study in the years 2010 or 2015 (with no
selection in respect of the results reported). Responses were returned by 71 (42%) of the recipients,
followed by further correspondence with some of them. Most of the respondents (n ¼ 53: 75%) reported
that the CMS procedure worked reliably in their hands. Of the others, 15 (21%) reported that the pro-
cedure was usually reliable, but not always (n ¼ 9: 13%) or not for all measures (n ¼ 6: 8%). Only three
respondents (4%) reported being unable to reproduce the characteristic effects, two of whom may be
using an insufﬁcient duration of CMS exposure. A series of analyses compared the 75% of ‘reliable’ labs
with the 25% of ‘less reliable’ labs on a range of experimenter, subject, stress and outcome variables. Few
if any signiﬁcant differences between these two samples were identiﬁed, possibly because of the small
size and diversity of the ‘less reliable’ sample. Two other limitations of the study include the (un-
avoidable) omission of labs that may have worked with the model but not published their data, and the
use of ad hoc measures to compare the severity of different stress regimes. The results are discussed in
relation to relevant published observations. It is concluded that CMS is in fact a rather robust model, but
the factors that result in a less effective implementation in a minority of laboratories remain to be ﬁrmly
established.
© 2016 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Chronic mild stress (CMS) is a well-validated and widely used
animal model of depression, based on the loss of responsiveness to
rewards by animals subjected to a varying schedule of minor
stressors. The CMS model was developed in the late 1980s, on the
basis of an earlier observation that rats subjected to a variety of
relatively severe stressors failed to increase their ﬂuid intake when
sucrose or saccharinwas added to their drinking water (Katz,1982).
The aims of the early CMS work were: to engender similar effects
using a much more mild and ecologically valid stress regime; to
explore the concept of stress-induced anhedonia by investigatingInc. This is an open access article
., Reliability of the chronic m
.08.001the effects of CMS on a variety of reward-related behavioural
endpoints; and to conﬁrm the utility of the model as a test-bed in
which to investigate the mechanisms of action of antidepressant
drugs (Willner et al., 1987, 1992). The CMS procedure was imple-
mented by exposing rats (or later, mice: Monleon et al., 1994) to a
relatively continuous variety of mild stressors, such as periods of
food and water deprivation, changes of cage mates, and other
similarly innocuous manipulations. Over a period of weeks of
chronic exposure the animals gradually reduced their consumption
of, and preference for, a preferred dilute sucrose solution, and this
deﬁcit could be reversed by chronic, but not acute, treatment with
antidepressant drugs. The development and validation of the CMS
model are described in more detail in earlier reviews, and in the
accompanying paper (Willner, 1997a, 2005, 2016).
As the CMSmodel was taken up by other labs in the early 1990s,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
ild stress model of depression: A user survey, Neurobiology of Stress
P. Willner / Neurobiology of Stress xxx (2016) 1e102concerns began to emerge about the reproducibility of the effects
reported. Inter alia, this concernwas highlighted by the fact that the
procedure became less reliable in the hands of the original research
group following a move to a different university. These issues, and
others, were debated in detail in a Special Issue of the journal
Psychopharmacology, which included a candid account of the ﬁrst
decade of CMS research (Willner, 1997a) and sixteen peer com-
mentaries. The response to the peer commentaries summarized the
position regarding the reliability of the CMS model as follows:
“some laboratories, including, currently, our own, have experienced
difﬁculty in (re)establishing the CMS procedure, but there are many
other laboratories in which the procedure operates reliably”
(Willner, 1997b). A later review summarized data from over a
hundred labs reporting depressive-like (and antidepressant-
reversible) effects of CMS across a wide range of depression-
relevant end-points, including sucrose or saccharine intake or
preference, sweet food intake, approach to sweet food, place con-
ditioning using a variety of drug and natural reinforcers, brain
stimulation reward, immobility in the forced swim test, learned
helplessness, male aggression and sexual behaviour, grooming, and
REM sleep latency (Willner, 2005). However, that review also
identiﬁed a handful of studies, including several published only as
meeting abstracts, reported ‘anomalous’ effects of CMS, such as
increased sucrose intake or brain stimulation reward (Willner,
2005).
Partly as a result of the uncertainty described in the 1997 and
2005 review papers, there has been a frequently expressed
assumption that the CMS procedure is unreliable or difﬁcult to
replicate, and reviews of animal models of depression typically
include a statement to this effect. However, this conclusion does
not sit comfortably alongside the burgeoning CMS literature,
which, as described in the accompanying paper, now amounts to in
excess of 1300 publications, that in the year 2015 alone include 230
papers from 180 labs in 30 countries (Willner, 2016). These statis-
tics, and the exponentially increasing uptake of the CMS model
(Willner, 2016), suggest that themodel may bemore reliable than is
typically assumed. The aims of the present studywere to attempt to
quantify the extent to which the CMS model is reliable and to un-
derstand some of the relevant factors. The main focus was on the
reliability with which CMS elicits the most widely used outcome, a
decrease in sucrose intake or preference.
Investigating the reliability of an experimental procedure pre-
sents particular problems because of the possibility that the pub-
lished literature represents the tip of an iceberg, with failures to
replicate and other evidence of unreliability lying below the sur-
face, unpublished. In order to take account of this issue, the present
study adopted a survey methodology in preference to a systematic
literature review, on the assumption that asking users about their
experience of working with the CMS procedure would be more
likely to yield insights into the problems they might have
encountered. Another methodological issue that needed to be
addressed at the outset is that different labs refer in different ways
to procedures that may be similar or may diverge: alongside CMS,
other labels include chronic unpredictable stress (CUS) and un-
predictable chronic stress (UCS), chronic unpredictable mild stress
(CUMS) and unpredictable chronic mild stress (UCMS), and chronic
varied or variate stress (CVS). It was decided to take an inclusive
approach to the survey, and this decision was vindicated by the
outcome: an analysis presented in the accompanying paper
(Willner, 2016), shows that empirically e and perhaps surprisingly
e these different labels carry no information about the severity of
the stress protocol and almost no information about the predict-
ability of stress. In this paper, therefore, CMS is used as a generic
term covering all of these procedures.Please cite this article in press as: Willner, P., Reliability of the chronic m
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2.1. Survey methodology
An initial PubMed search using the search terms [chronic (mild
or varied or unpredictable) stress] returned over 3000 hits. In order
to narrow this literature down, the search was repeated for single
years at 5-year intervals from 1990 to 2015 (with the ﬁnal search on
December 31, 2015), and the outputs were searched by hand to
identify papers involving varied stress regimes in animals. Studies
in people and animal studies involving repeated presentation of a
single stressor were excluded. This search indicated an exponential
increase in publications, rising above 100 in 2010. The years 2010
and 2015 were chosen for further investigation, on the basis that
authors publishing in 2015 had recent experience with the CMS
methodology, while those publishing in 2010 might have encoun-
tered difﬁculties that had caused them to cease working with the
model, but should still have a good memory of their experiences.
Papers from 2010 and 2015 were ordered by country and region, in
order to identify independent laboratories, and email addresses
were collected where easily available from PubMed abstracts or
open access publications, supplemented in a few cases by addresses
already known to the author.
Each of the labs for which an email address was identiﬁed was
sent a survey, created using Google Forms, and asked to return it via
a web link. A total of three further requests were made to non-
responders. Following receipt of an email explaining that Google
was not readily available in China, the second and third requests to
Chinese recipients invited them to return the survey via email; this
offer was also extended to other respondents at the third request.
The survey covered the basics of the methodology used, followed
by sections probing within-experiment reliability and between-
experiment reliability. The survey is not presented in detail
because many of the questions returned indeterminate answers,
such as a high proportion of missing or ambiguous responses. De-
tails of the questions for which responses could usefully be
analyzed are presented in the Results section.
Subsequently, follow-up questionnaires were emailed (i) to re-
spondents who indicated that in their lab the procedure was
“usually reliable but not always”, to probe the nature of unreliable
performance and potential differences between more and less
successful experiments, and (ii) to respondents who indicated that
they did not use a sucrose intake or preference test. Again, details of
the questions asked are presented in the Results section.
2.2. Estimation of CMS intensity
In order to compare the severity of different stress regimes a
two-stage Delphi procedure was used to obtain ratings from ﬁve
experts with extensive use of the CMS procedure. A list of 26 micro-
stressors was compiled from responses to the survey, each of which
was rated independently by the ﬁve raters, using a 5-point scale of
severity. The ratings were then shared, anonymously, with the
other raters, together with a few comments made on the ﬁrst
round. The ratings were then repeated, this time with separate
ratings for rats and mice. Kendall's coefﬁcient of concordance was
used to assess the degree of agreement between the ﬁve raters.
Concordance was relatively low on the ﬁrst round (W ¼ 0.45,
p < 0.001), and increased somewhat on the second round but
remained below the minimum acceptable level of 0.6 (rats:
W ¼ 0.53; mice: W ¼ 0.59). Considering that the raters included
two rat experts and two mouse experts, plus the author, the
concordance was calculated for three raters for each species (the
two relevant experts plus the author). Both analyses achieved
concordances of W ¼ 0.75 (p < 0.001). The median of these threeild stress model of depression: A user survey, Neurobiology of Stress
P. Willner / Neurobiology of Stress xxx (2016) 1e10 3ratings for each micro-stressor and species was then used to
construct three measures to characterize the different stress re-
gimes: Variety (the number of elements included), Severity (the
proportion of elements rated as 4 or 5) and the overall Burden of
stress (the sum of the ratings across all of the micro-stressors
identiﬁed). The Burden measure in particular is a very rough and
ready estimate that does not take account of the frequency or
duration of each element, that the severity of individual elements
may vary markedly between laboratories, or that combinations of
stressors are sometimes applied; this caveat also applies, to a lesser
extent, to the Variety and Severity measures.
3. Results and discussion
A total of 245 labs were identiﬁed as publishing in 2010 (n¼ 81)
and 2015 (n ¼ 181), with a surprisingly low proportion (6.5%)
represented in both years (Table 1). A total of 170 survey requests
were mailed out, representing 70% overall of the labs identiﬁed as
publishing in those years. A total of 71 responses were received,
representing a 42% return overall, with a relatively low return (17%)
from China but a 60% return from other regions. This was a rela-
tively experienced sample: while fourteen respondent had per-
formed only one (n¼ 8) or two (n¼ 6) CMS experiments, many had
conducted 3e5 experiments (n¼ 15), and themajority (n¼ 41) had
completed more than 5 experiments. As some of the respondents
asked for their responses to be treated anonymously, none of the
respondents have been identiﬁed by name. (For audit purposes,
respondents are identiﬁed by their location in the database.)
3.1. Overall reliability of the CMS procedure
Only three of the 71 respondents reported that they do not
typically see a depressive phenotype. One of these respondents
(R11) had nonetheless published at least ﬁve papers reporting
anhedonic-like effects of CMS. The other two (R31, R38) used very
brief (10 and 14 days) periods of CMS exposure, compared with a
modal duration of stress exposure among the other respondents of
3e4 weeks, with 70% of respondents (37/53) reporting that more
than 2 weeks of stress exposurewas needed to see an effect of CMS,
as documented in literally hundreds of publications.
Initially, twenty four respondents (34%) reported that CMS was
“usually but not always” reliable. However, nine of these clariﬁed
that what theymeant by this was that “Effects of stress were always
signiﬁcant but some individual animals failed to respond”. This left
15 respondents (21%) reporting genuine unreliability (in addition to
the three respondents who reported a generally negative experi-
ence). However, six of these respondents (R1, 32, 46, 63, 68, 69)
reported that “Stress did not reliably decrease sucrose intake/
preference but did reliably elicit other depression-like effects”. Of
the other nine respondents, three (R5, 48, 57) reported that “Effects
of stress were present in every experiment, but not always statis-
tically signiﬁcant”, one (R26) reported that CMS was effective in
one rat strain but not in another, and only ﬁve respondents (R13, 22,Table 1
Survey demographics.
Number of labs identiﬁed Survey
requests
Responses
2010 2015 Total % Overlap Sent % Received %
Europe 25 23 43 11.6 29 67 16 55
North America 11 29 39 2.6 34 87 25 74
China 33 93 118 6.8 76 65 13 17
Rest of World 12 36 46 4.3 31 67 17 55
Total 81 181 246 6.5 170 70 71 42
Please cite this article in press as: Willner, P., Reliability of the chronic m
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stress had no apparent effect”.
A possible under-estimate of unreliability arises from the fact
that some respondents (n ¼ 16) reported that they did not use a
sucrose intake/preference test, raising the possibility that the
reason was that they had tried it and found it unreliable. A follow-
up query to these respondents elicited 14 replies. Nine respondents
said that they had never tried the sucrose test, two said that they
had used the sucrose test and found it to be reliable, but now
preferred to use other measures, and one (R29) reported using a
sweet food test in preference. Only two of these respondents said
that they did not use the sucrose test because it did not work
reliably, and one of these (R54) explained that this was because of
excessive spillage fromwater bottles. Only a single respondent (R1)
reported not using the sucrose test because of unreliability of CMS
effects, and as already reported above, this respondent did see
reliable effects on other behavioural measures.
Overall, therefore, a total of twelve respondents (17%) reported
that CMS sometimes failed to produce depressive-like effects (nine
of whom nonetheless reported that they found CMS to be “usually
reliable”), with a further six respondents (8%) reporting unreli-
ability of the sucrose intake/preference test but a reliable response
on other measures. As described below, a series of further analyses
was carried out comparing these 18 respondents with the other 53
(75%), in relation to experimenter, subject, stress, and outcome
variables. An initial analysis compared the experience of the two
groups. There was a tendency for labs in the ‘less reliable’ group to
have conducted more CMS experiments than those in the ‘reliable’
group, which is to be expected: the more experiments undertaken,
the greater the likelihood of seeing an occasional failure. However,
the difference is not statistically signiﬁcant (Fisher's exact test:
proportion of labs conducting >5 experiments, 72% vs 54%,
p ¼ 0.267; proportion conducting >2 experiments, 94% vs 75%,
p ¼ 0.096).
Reports of the overall reliability of the CMS procedure did not
map as clearly as one might wish onto another estimate of reli-
ability, the proportion of animals responding to CMS. As shown in
Table 2, while 27 (56%) of the labs reporting reliable effects of CMS
estimated that >75% of animals responded, 7 of them (15%) esti-
mated a relatively low response rate (<50%). Nevertheless, the
proportion of animals responding to CMS was signiﬁcantly greater
overall in labs reporting that CMS produced a reliable depressive-
like phenotype (Chi-square ¼ 8.0, p < 0.02, after amalgamating
the two ‘less reliable’ groups). This is despite the fact that only
around a third of the respondents were able to specify the criterion
they used to deﬁne an individual ‘responder’, and these criteria
varied considerably. Overall, 85% of respondents reported that
>50% of animals responded to CMS, or 80% if the three labs that
reported not seeing a depressive phenotype are included in the
calculation.
Signiﬁcantly, the three respondents who reported not seeing a
depression-like phenotype all said that they see no effect of CMS on
prototypical depression-like parameters, rather than an effect in
the ‘wrong’ direction (such as increased sucrose intake/preference
or decreased immobility in the forced swim test). That is, none of
the 71 respondents to this survey reported seeing the ‘anomalous’
effects of CMS that are sometimes reported (Willner, 2005), sug-
gesting that these effects are rather rare.
3.2. Experimenter variables
Two of the respondents (R1, 9) who reported not seeing reliable
effects of CMS on sucrose intake reported that they nonetheless had
at one time had aworker in their labwho did reliably see this effect,
which they were unable to explain. Another respondent (R63)ild stress model of depression: A user survey, Neurobiology of Stress
Table 2
Proportion of animals reported as ‘responding’ to CMS in relation to estimates of the overall reliability of the model.
n Proportion responding
25-50% 50-75% >75%
Effects sometimes absent, or present but nonsigniﬁcant 9 2 6 1
Sucrose intake less reliable than other measures 6 0 4 2
CMS produces a reliable depressive phenotype 47 7 13 27
This table omits some labs that did not supply data on the proportion of responders, which includes the three labs where CMS was found to be ‘unreliable’.
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will wreak havoc with the protocols”, which provides the basis for
one potential explanation.
Experimenter effects have been previously described in relation
to other behavioural paradigms (Crabbe et al., 1999), with the
suggestion that “Different experimenters … probably presented
idiosyncratic arrays of odor cues and handled the mice somewhat
differently” (Wahlsten et al., 2003). The potential effect of odour
cues in the present context was examined in two ways. A ﬁrst
question was whether lab personnel were allowed to wear per-
fumes or deodorants. The proportions of labs that forbade these
sources of odour cues were 9/18 (50%) in the ‘less reliable’ group of
labs, and 29/53 (55%) in the ‘reliable’ group: essentially, the same. A
second questionwas the direction of air ﬂow:whether pheromones
were transmitted from animals to people or from people to ani-
mals. (This was a potentially signiﬁcant factor in the author's own
experience: the loss of CMS reliability coincided with a change of
animal house from one with animals-to-people airﬂow to one with
people-to-animals airﬂow.) The proportions of animal houses
exposing animals to human pheromones from people to animals
was 2/13 (15%) in the ‘less reliable’ group of labs and 6/32 (19%) in
the ‘reliable’ group of labs: again, essentially the same. Despite
these negative results, one respondent (R2) pointed out that, given
rodents' extreme olfactory sensitivity, it is very likely that their
behaviour could be inﬂuenced by odorants such as perfumes, de-
odorants or detergents, and therefore these potential sources of
error should be proscribed.3.3. Subject variables
An initial examination of species used found that the group of 18
‘less reliable’ labs included 5 working with mice, 9 working with
rats and 4 working with both species, compared with 25, 26 and 2
labs in the ‘reliable’ group. Notably, however, 40% of mouse labs
(the same proportion among the ‘less reliable’ and ‘reliable’ groups)
did not use the sucrose intake test, comparedwith only 9% of the rat
labs (Fisher exact test, p < 0.005). The fact that the sucrose test is
used more frequently in rats than in mice raises the possibility that
the test may work better in rats, as suggested by some respondents
(notwithstanding that when asked, most of the non-users reported
that the decision not to use the sucrose test was not based on their
own experience). If this is the case, it could reﬂect either a differ-
ential effect of CMS or, perhaps more likely, the greater difﬁculty of
measuring ﬂuid intakes accurately in smaller animals.
The major strains used, across labs, were Sprague Dawley (SD)
and Wistar rats and C57BL/6 and BALB/c mice. SD and Wistar rats
were used, respectively, by 4 and 4 labs in the ‘less reliable’ group
and by 10 and 12 labs in the ‘reliable’ group, suggesting no differ-
ence in susceptibility between these two rat strains. The twomouse
strains were used, respectively, by 3 and 3 labs in the ‘less reliable’
group of labs and by 3 (BALB/c) and 16 (C57BL/6) labs in the ‘reli-
able’ group; this difference, while suggestive, is not signiﬁcant
(p > 0.1). Indeed, while C57BL/6 mice are usedmore frequently, two
respondents (R31, 41) suggested that they are actually lessPlease cite this article in press as: Willner, P., Reliability of the chronic m
(2016), http://dx.doi.org/10.1016/j.ynstr.2016.08.001susceptible to CMS than BALB/cmice. This would be consistent with
published studies reporting that BALB/c mice are more susceptible
than C57BL/6 mice to CMS (Grifﬁths et al., 1998; Ducottet and
Belzung, 2004, 2005) and in other stress paradigms (Anisman
et al., 1998, 2001; Razzoli et al., 2011a,b; Savignac et al., 2011).
(Although C57BL/6 mice are not the most resistant strain: in a
different comparison DBA/2 mice were more resistant than C57BL/
6 mice to CMS effects on sucrose intake, with CBA/H mice the most
susceptible among the strains tested: Pothion et al., 2004.) There
are several other reports in the literature of strain differences in
sensitivity to CMS, with increased responsiveness reported for
Flinders Sensitive Line rats (Pucilowski et al., 1993), and for several
genetically modiﬁed mouse strains (CB1 knockout: Valverde and
Torrens, 2012; OCT2 null mutant: Courousse et al., 2014;
VGLUT1þ/: Garcia-Garcia et al., 2009).
Sex was mentioned by 12 respondents as a critical factor
determining the effects of CMS in their hands, but generally
without specifying the direction of effect, and with mixed ﬁndings
reported by those who did provide more detail. Recent systematic
reviews of sex effects in CMS report a similar mixed picture (Dalla
et al., 2010; Franceschelli et al., 2014). Four respondents mentioned
age as a factor, with greater susceptibility to CMS in middle-aged
rats relative to younger animals. There is some support in the
literature for this observation (Herrera-Perez et al., 2008; Toth et al.,
2008). A greater response in middle-aged rats relative to older
animals was also mentioned (R43, 49, and Pardon et al., 1994).
There are other isolated reports of effects of factors such as rearing
conditions, endocrine status and nutritive status (Willner, 2005,
Table 7). Finally, one respondent (R57) reported the experience
from three separate labs of a difference in susceptibility to CMS in
rats of the same strain from different US suppliers. A recent paper
reported differences in susceptibility to CMS among outbredWistar
rats from three different European suppliers (Theilmann et al.,
2016) and similar effects have been documented in other behav-
ioural paradigms (e.g. Palm et al., 2012; Goepfrich et al., 2013;
Browne et al., 2015).3.4. Stress variables
As noted earlier, two of the three respondents who did not
typically see a depression-like phenotype following CMS used a
relatively short exposure (<2 weeks). However, as shown in
Table 3A, the overall duration (days) of stress exposure was (non-
signiﬁcantly) longer in the labs reporting ‘less reliable’ effects.
Nevertheless, three respondents in the ‘less reliable’ group (R26, 46,
63) stated that in their experience the duration of stress needed to
be at least six weeks, consistent with a published report that mice
of the relatively stress-insensitive C57BL/6 strain displayed a reli-
able depressive-like phenotype after an 8-week CMS regime but
not after 4 weeks of CMS (Monteiro et al., 2015). Table 3A also
compares the two reliability groups on the three measures of CMS
intensity: Variety, Severity and Burden. Again, no notable differ-
ences were seen. The same variables were examined in relation to
the proportions of animals responding to CMS (Table 3B). Again,ild stress model of depression: A user survey, Neurobiology of Stress
Table 3
Characteristics of the CMS protocol in relation to estimates of its reliability.
n Duration Variety Severity Burden
A: Reliable?
Yes 51 22.7 (1.5) 7.2 (0.2) 0.36 (0.02) 20.7 (0.8)
Less so 14 26.0 (4.1) 7.7 (0.4) 0.32 (0.05) 21.8 (1.3)
B: % responding
25-50% 8 21.8 (3.1) 6.8 (0.9) 0.35 (0.07) 19.5 (2.2)
50-75% 20 24.7 (2.8) 7.8 (0.3) 0.35 (0.04) 22.6 (1.1)
>75% 26 24.1 (2.4) 7.1 (0.3) 0.33 (0.03) 20.2 (1.0)
Duration: number of days of CMS; Variety: number of micro-stressors applied;
Severity: proportion of micro-stressors rated 4 or 5 on the 5-point severity scale;
Burden: total of all stress ratings. Values are mean (standard error). Six responses
were excludedwhere respondents reported using bothmice and rats, because it was
uncertain whether the stress regime reported was applied to one species or to both.
In B, there were additional omissions where the proportion responding was not
reported.
P. Willner / Neurobiology of Stress xxx (2016) 1e10 5there were no differences on any of the four stress variables. Table 3
reports combined data for rats and mice, but the picture is un-
changed if the two species are examined separately.
The most frequently used micro-stressors are listed in Table 4.
There were signiﬁcant or near-signiﬁcant differences in the use of
certain micro-stressors in mice and rats: in particular, food and
water deprivation are less frequently usedwithmice thanwith rats.
However, for no individual micro-stressor was there a signiﬁcant
difference in use between ‘reliable’ and ‘less reliable’ labs, or be-
tween labs reporting different proportions of animals responding
to CMS (cf. Table 3). Nevertheless, seven respondents commented
that they had modiﬁed the procedure either to increase the in-
tensity of the CMS regime or to reinstate certain micro-stressors
that led to a decrease in efﬁcacy of CMS when removed. Exam-
ples included replacing cage tilt with exposure to predator odour
(R49) or presenting two micro-stressors simultaneously (R45). Just
over half of the respondents (57%) said that their procedure was
based on the original CMS publications (Willner et al., 1987, 1992),
with others citing more recent studies from other labs. However,
when taking into account both composition (micro-stressors
included) and delivery (ﬁxed/random) it was not possible to
identify any two CMS schedules that were identical, either for rats
or mice.
The use of food andwater deprivation bymost labs is relevant to
the question of whether the effect of CMS on sucrose intake is
inﬂuenced by changes in body weight. This was suggested as the
decisive factor in early work from one lab which reported that the
effect of CMS on sucrose intake was non-signiﬁcant when
expressed in relation to body weight, which increases more slowly,Table 4
Most frequent components of the CMS regime.
Micro-stressor % Overall % Mice % Rats P
Wet bedding 79 83 71
Cage tilt 75 87 66 0.049
Light-dark reversal 72 73 71
Food deprivation 70 57 86 0.013
Water deprivation 65 47 83 0.004
Immobilization 52 63 40 0.083
Crowding 42 30 51
Loud noise 39 40 37
Stroboscopic lighting 38 30 46
Forced swim 34 33 37
Cold swim 28 30 23
The most frequently used micro-stressors are shown overall and separately for mice
and rats. The frequency of use of other micro-stressors was <20%. The right-hand
column shows the results of Fisher's exact test for those micro-stressors where
there was a signiﬁcant or near-signiﬁcant species difference (highlighted in bold).
Please cite this article in press as: Willner, P., Reliability of the chronic m
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1995; Forbes et al., 1996). Many other studies, however, demon-
strated that CMS was effective even after correcting for changes in
body weight (reviewed byWillner, 1997a; see Papp et al., 2016 for a
recent example). Of note, eight of the present respondents reported
using sucrose intake/body weight as their primary outcome mea-
sure, and seven of these (R2, 8, 10, 12, 37, 50, 58) reported reliable
effects of CMS. Another signiﬁcant aspect of the present data is that
while around two thirds of labs do use food and water deprivation,
around one third of labs do not, and CMS is equally effective in both
cases. Also relevant to this debate is that 11/12 labs in the ‘less
reliable’ group and 37/43 labs in the ‘reliable’ group reported using
loss of sucrose preference rather than decreased sucrose intake as
the outcome measure, which is unrelated to lower body weight.
Overall, the present data support the earlier conclusion that CMS
effects cannot be explained away as an artefact of metabolic
changes.
3.5. Outcome variables
Most respondents reported that they conduct the sucrose intake
test in the animal's home cage rather than moving it to a test cage,
and this variable did not differ between reliable and ‘less reliable’
labs (4/33: 12% vs. 2/12: 17%). However, in relation to the timing of
tests there are hints of diurnal and circannual effects. One
respondent (R46) reported seeing stronger CMS effects when
testing was at the start of the dark phase of the light-dark cycle, as
reported in earlier published study (D'Aquila et al., 1997a). But a
more recent study using a different experimental design reported a
different pattern of diurnal effects (Aslani et al., 2014), and Papp
(2012) recommends testing at the start of the light cycle, so there
is no consensus on the best time of day to test. Three respondents
(R46, 57, 68) indicated that CMS may be less effective in the sum-
mer months. Circannual effects have not been formally studied in
the CMS model, but there is some evidence for their existence in
other stress paradigms (Borsini et al., 1990; Meyer et al., 2006;
Kiank et al., 2007; Han et al., 2014).
Two important variables in the sucrose intake/preference test
are the extent of food/water deprivation immediately prior to the
test and the concentration of the sucrose solution. (The survey did
not ask about the duration of the sucrose test but this is typically
related to the duration of food/water deprivation, with brief
deprivation (0e1 h) usually preceding a prolonged (e.g. overnight
or 24 h) test and long deprivation (e.g. 12 h) usually preceding a
brief (e.g. 1 h) test). The majority of respondents (41/57: 72%) re-
ported using relatively long periods of deprivation (3e11 h, n ¼ 9;
>12 h, n ¼ 32). This was similar between rat and mouse labs, and
also between reliable and ‘less reliable’ labs. However, some dif-
ferences were found in the concentrations of sucrose used in
different labs. All but one (R35) of the mouse labs reporting these
data (14/15: 93%) used 1% sucrose, but among rat labs, only 18/30
(60%) used 1% sucrose with the other 12 labs using concentrations
of 2% or higher (Fisher exact test, p¼ 0.034). Further examination of
the rat data showed that most (16/22: 73%) of the labs reporting
reliable data used 1% sucrose, whereas most (6/8: 75%) of the ‘less
reliable’ labs used more concentrated (2e5%) sucrose solutions
(Fisher exact test, p¼ 0.034). This suggests (albeit weakly, given the
low numbers and the fact that the effect was seen only in rats) that
it may be important for CMS reliability in the sucrose test that the
sucrose solution is only weakly rewarding.
Some labs do not use the sucrose test (as discussed above) and
not all of those that do see it as their primary behavioural endpoint.
Table 5 lists the primary outcome measures reported. The table
separates out the ‘less reliable’ group of labs into two subgroups:
those (group 1: n ¼ 12) reporting that CMS was unreliable (n ¼ 3),ild stress model of depression: A user survey, Neurobiology of Stress
Table 5
Outcome measures used, as a function of reported reliability.







n ¼ 12 % n ¼ 6 % n ¼ 18 % n ¼ 53 % N ¼ 71 %
Sucrose/saccharin/sweet food intake/preference 7 58 7 39 23 45 30 42
Forced swim test 2 34 2 11 11 20 13 18
Anxiety (includes exploration tests and fear conditioning) 1 8 1 17 2 11 7 13 9 12
Grooming (includes coat state and splash test) 3 50 3 17 1 2 4 6
Multiple measures 3 25 3 17 1 2 4 6
Spatial cognition 1 8 1 6 3 7 4 6
Physiological measures 3 5 3 4
Alcohol intake 2 4 2 3
Other 2 4 2 3
P. Willner / Neurobiology of Stress xxx (2016) 1e106or “usually but not always reliable” (n ¼ 9), and those (group 2:
n¼ 6) reporting that CMS “did not reliably decrease sucrose intake/
preference but did reliably elicit other depression-like effects”.
Unsurprisingly, those labs in which CMS was reported to work
reliably for measures other than the sucrose test (group 2) did not
use the sucrose test as their primary outcome variable. Two other
trends are visible in the data: the labs reporting reliable CMS effects
(group 3: n ¼ 53) tended to use a broader range of outcome mea-
sures; and none of the labs in group 1 reported using the forced
swim test for their primary outcome. However, neither of these
trends was statistically signiﬁcant.
Different labs varied inwhen outcome tests were performed: 28
labs gave a single test at the end of the CMS procedure; 8 labs
administered tests before and after CMS; and 31 labs tracked the
effect of CMS at least weekly (typically using a sucrose or coat-state
test). Repeated testing makes it possible to establish a pattern of
effects, such as a rapid habituation of early CMS effects or an un-
stable control baseline. (The latter effect, but not the former, could
also be detected by testing twice, before and after CMS.) Those
respondents who reported that effects of CMS were less than reli-
able were asked whether either of these patterns was present.
None reported seeing early effects of stress that rapidly habituated,
as reported in several studies (D'Aquila et al., 1997b; Pothion et al.,
2004; Schweizer et al., 2009), but four respondents (R42, 46, 48, 49)
reported that, while stress appeared to decrease sucrose intake, the
behaviour of the control group also changed, suggesting that a
component of unreliability may be that control animals were
inadvertently stressed. This could easily occur if controls and CMS
animals are housed in the same room, a procedure which should
strictly be avoided.4. General discussion
4.1. How reliable is the CMS model?
A recent review of animal models of depression offers the
following summary: “Chronic mild stress utilises the anhedonic
responses as measured by a reduction in consuming a sweet so-
lution (a pleasurable activity) following a series of mild stressors…
However, this model has had difﬁculties in being replicated in all
laboratories” (Kelly, 2009). This is a sentiment commonly encoun-
tered in the literature, sometimes in a more extreme form. Indeed,
according to the Wikipedia article on Animal Models of Depression
(2016) “The chronic mild stress (CMS) model is probably the most
valid animal model of depression (… but the) data can be hardly
replicated”. Similarly, the Encyclopedia of Behavioral Neuroscience
states that “(The CMS model) has very poor reliability and CMS-
induced effects could not be reproduced in many laboratories …Please cite this article in press as: Willner, P., Reliability of the chronic m
(2016), http://dx.doi.org/10.1016/j.ynstr.2016.08.001(The) model has fallen out of favour due to the lack of cross-
laboratory reliability” (Cryan, 2010). Considering the steady rise
in the number of CMS publications, and the fact that the number of
labs publishing CMS studies more than doubled from 81 in 2010 to
180 in 2015, the notion that the CMS model “has fallen out of
favour” is clearly false. The main aim of the present investigation
was to establish what difﬁculties users of the CMS model actually
experience, and whether the accepted notion that the procedure is
difﬁcult to replicate stands up to scrutiny.
It is certainly true that in the early years (pre-2000) many labs
experienced difﬁculties in reproducing CMS effects and this gave an
impression of unreliability, summarized in an inﬂuential review in
the following terms “… the behavioral abnormalities produced by
chronic stress… have been difﬁcult to replicate across laboratories,
which has reduced their general application” (Nestler et al., 2003).
Nevertheless, a slightly later review commented that “… while the
CMS model can undoubtedly prove difﬁcult to establish … the
above conclusion appears to be based on the literature as it existed
some years ago, and reveals a lack of familiarity with the explosion
of more recent publications” (Willner, 2005). Indeed, the present
data, which describe the situation a decade later, demonstrate that
the reproducibility of CMS effects is no longer a serious concern.
An overwhelming majority of the respondents to the present
survey (n ¼ 53: 75%) reported that the CMS procedure worked
reliably in their hands. Of the others, 15 (21%) reported that the
procedure was usually though not always reliable, (n ¼ 9: 13%), or
that they had difﬁculty with the sucrose test but not with other
measures (n ¼ 6: 8%). Only three respondents (4%) reported being
unable to reproduce the characteristic effects, two of whommay be
using an insufﬁcient duration of CMS exposure. And even the single
respondent who ﬁnds the CMS procedure to be unreliable after an
adequate trial has actually published a string of papers reporting
anhedonic-like effects of CMS. A limitation of the study is that this
was not a representative sample. The questionnaire could not be
circulated to research groups that may have worked unsuccessfully
with the CMSmodel but not published their data, as such labs could
not be identiﬁed. However, in relation to the potential respondents
identiﬁed as having published a CMS study in the two years
examined (2010 and 2015), the only selection criterion was that
they should have a readily accessible email address: no selection
was applied in respect of the results reported. Except for China
where the response ratewas lower, therewas an excellent response
rate (60%), and respondents were guaranteed anonymity. So if re-
spondents had experienced difﬁculties with the CMS model,
whether or not these were apparent in their publications, there is a
reasonable presumption that this should have been reﬂected in
their responses to the survey. The fact that such reports were
minimal does suggest that the reproducibility of CMS effects is veryild stress model of depression: A user survey, Neurobiology of Stress
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4.2. Can critical factors be identiﬁed?
The second aim of the study, to identify the critical factors in
reproducibility of CMS effects was less successful. Very few differ-
ences were identiﬁed between the 75% of ‘reliable’ labs and the 25%
of ‘less reliable’ labs on awide range of experimenter, subject, stress
and outcome variables. This may to some extent reﬂect the small
size and, particularly, the diversity of the ‘less reliable’ sample,
which contains at least four very small sub-groups. Therefore, the
results of these analyses were presented in the context of the
published literature. While few if any deﬁnitive conclusions can be
drawn, a number of factors are worthy of comment.
Individual differences, in relation to both experimenters and
experimental subjects, are clearly of importance even if few general
conclusions emerge. It is particularly striking that even the
respondent reporting the most negative overall picture (R9) could
identify a speciﬁc worker who did obtain reliable data over a pro-
longed period. Differences between experimenters, either intrinsic
(e.g. pheromonal) or extrinsic (e.g. training), could be expected to
account for some of the individual variability in CMS outcomes, as
has been suggested in other behavioural contexts (e.g. Wahlsten
et al., 2003), even though the present survey did not identify
relevant factors.
Differences between experimental subjects have been better
characterized, though again, the relevant data are in the literature
rather than the present results. Perhaps the best characterized ef-
fect is the differential stress susceptibility of C57BL/6 and BALB/c
mice. This difference was not, however, apparent within the pre-
sent data-set, and while the literature is clear that C57BL/6 mice are
more resilient to a variety of stressors than BALB/c mice, the greater
use of the former strain by respondents to the survey testiﬁes to the
greater popularity of C57BL/6 mice as experimental subjects. While
rat strains also differ in their susceptibility to stressors (for
example, greater responsiveness in FSL or Wistar-Kyoto strains),
the literature does not suggest differential stress responsiveness
between the Wistar and Sprague-Dawley strains most commonly
used in CMS research.
A related issue, which was touched on only in passing in the
survey, is variability within populations of animals of the same
strain. It is usually regarded as an inconvenience that there is
typically a sub-group of animals that do not respond to CMS.
However, two groups have promoted as a virtue the fact that it is
possible to optimise the procedure so as to identify subgroups of
CMS-susceptible and CMS-resilient rats (Wiborg, 2013) and mice
(Strekalova and Steinbusch, 2010), because they can then be used to
study the neurobiological mechanisms underlying stress suscepti-
bility and resilience (e.g. Couch et al., 2013; Nieto-Gonzalez et al.,
2015). Individual susceptibility to CMS has been related to high
levels of anxiety (Ducottet et al., 2004; Ducottet and Belzung, 2005;
Li et al., 2010) and to a socially submissive behavioural trait
(Strekalova et al., 2004, 2011), factors that are rarely measured as
baseline variables in CMS experiments. There is also a suggestion
that CMSmay work best in middle-aged animals, thoughmore data
are needed on this point. The potential for individual differences to
contribute to variability of outcomes cannot be over-emphasized:
for example, Strekalova et al. (2011) observed that, in different
studies using C57BL/6 mice, the proportion of socially submissive
animals varied between 15 and 85%.
Judging from responses to the survey, the study did not support
the view, often expressed, that CMS is more difﬁcult to implement
in mice than in rats. However, the sucrose test is used signiﬁcantly
less frequently withmice thanwith rats. As with some other results
reported here, it is not clear to what extent this reﬂects a genuinePlease cite this article in press as: Willner, P., Reliability of the chronic m
(2016), http://dx.doi.org/10.1016/j.ynstr.2016.08.001species difference in ease of use, or simply a personal preference for
using a different test, such as the coat-state (grooming) test (Nollet
et al., 2013), which is often usedwith mice but only rarely with rats.
However, it is certainly the case that sucrose intake is more vari-
able, and therefore less accurate, in mice than in rats (Strekalova
and Steinbusch, 2010), and some evidence-based guidelines exist
for increasing the accuracy of the test in mice, including pre-
exposure to sucrose to overcome neophobia, switching bottle po-
sitions to overcome side preferences, the use of a prolonged two-
bottle preference test, and measures to reduce spillage
(Strekalova and Steinbusch, 2010; Strekalova et al., 2011). Guide-
lines for rat studies suggest that reliability can be improved by
screening animals before CMS to exclude those (typically around
20%) with very low, very high or very variable sucrose intakes
(Papp, 2012).
One factor that was signiﬁcantly different between the ‘reliable’
and ‘less reliable’ groups of labs was the sweetness of the sucrose
solution, with more concentrated sucrose solutions tending, in rats,
to be associated with less reliable results. While this result could
represent a type 1 error, considering the overall number of com-
parisons between the two groups of labs, there is a basis for
thinking that it could be genuine. The concentration-intake curve
for sucrose is bell-shaped (at least in brief tests in rats), and this
means that at higher concentrations, a single-bottle sucrose test, or
a two-bottle sucrose/water preference test, does not provide a good
measure of hedonic value. When comparing medium and high
sucrose concentrations, the stronger solution appears less
preferred in a choice between sucrose and water, but in a test of-
fering a choice between two sucrose solutions the stronger solution
is always preferred (Phillips et al., 1991; Muscat et al., 1991; Willner
et al., 1991). In other words, if the concentration of sucrose is too
high, a decrease in its rewarding value may not be expressed as a
decrease in intake (or in preference with respect to water). A
dissociation between intake and reward is also seen with sweet
food: for example, CMS was found to increase rats' intake of very
sweet food, as is also seen in depressed people, while at the same
time decreasing the rate of eating, consistent with a decrease in
reward value (Sampson et al., 1992). A decrease in sucrose prefer-
ence may be very difﬁcult to detect if preference is similar at the
sucrose concentration selected for testing and at lower concen-
trations (cf. Pothion et al., 2004). The optimal sucrose concentration
for testing the anhedonic effect of CMS is one that engenders a clear
preference over water, but is on the ascending limb of the
concentration-intake curve. This would be expected to vary be-
tween strains and species, and should be determined empirically in
each case, since problems are to be expected if the sucrose con-
centration is too high. In line with this reasoning, it is recom-
mended that, whenworking with rats, “the sucrose solution should
not exceed 2%” (Papp, 2012).
Another factor that has been reported to inﬂuence the effec-
tiveness of CMS is the severity of the stress regime, as commented
by some of the respondents to the survey. The ‘reliable’ and ‘less
reliable’ groups of labs did not differ on any of the measures con-
structed to compare the intensity of different stress regimes, but as
already acknowledged, these were crude measures that did not
take into account the duration of individual micro-stressors or how
exactly theywere applied. In one of very few studies to examine the
effect of parametric variation of CMS intensity, Strekalova and
Steinbusch (2010) reported on the greater efﬁcacy of a more
intense CMS regime to decrease sucrose intake in mice, where in-
tensity was deﬁned by features such as the duration or proximity of
individual micro-stressors. In an early study, Muscat and Willner
(1992) reported that a continuous and varied CMS regime
decreased sucrose intake to a greater effect than a subset of micro-
stressors presented at night only, and that a subset of ‘proximal’ (in-ild stress model of depression: A user survey, Neurobiology of Stress
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singly housed) or wet bedding, was able to decrease sucrose intake,
while a subset of ‘distal’ (out-of-cage) stressors was not. In these
experiments, daily presentation of only one element of the ‘prox-
imal’ set, paired housing, was sufﬁcient to maintain a low level of
sucrose intake for up to three weeks. However, this particular social
stressor was neither a necessary component of the CMS regime,
since combinations of stressors that excluded this element were
also effective, nor a sufﬁcient component, since with more pro-
longed administration, repeated pairing alone in the absence of
other stressors led to habituation of the response (Muscat and
Willner, 1992). Nevertheless, a more intense social stressor,
repeated exposure to social defeat does elicit a sustained decrease
in rewarded behaviour in rats (Willner et al., 1995; von Frietag et al.,
2000; Rygula et al., 2005; Miczek et al., 2011) and mice (Krishnan
et al., 2007; Yu et al., 2011; Zhang et al., 2015).
The probable inﬂuence of CMS intensity on experimental out-
comes raises the question of how this should be assessed. The
measures used here were based on subjective estimates of the in-
tensity of the individual micro-stressors, and notwithstanding that
the estimates were arrived at through expert consensus, this
cannot be considered to be a reliable method, and is not recom-
mended. Loss of body weight relative to control animals may pro-
vide a more reliable measure of CMS intensity. In some studies,
subgroups of rats (Remus et al., 2015) or mice (Strekalova and
Steinbusch, 2010; Tang et al., 2013) that displayed vulnerability to
a CMS-induced decrease in responsiveness to rewards also showed
a relative loss of body weight, while animals that were resilient to
induction of anhedonia did not. The relationship between CMS
effects on hedonic parameters and body weight is far from abso-
lute: anhedonic effects are sometimes seen in the absence of an
effect on body weight in both rats (e.g. Muscat and Willner, 1992;
Papp et al., 1992; Valverde et al., 1997) and mice (Grifﬁths et al.,
1992; Pothion et al., 2004), and the opposite effect, a relative
decrease in bodyweight in the absence of changes in sucrose intake
or preference, has also been seen (Gouirand and Matuszewich.
2005; Chang and Grace, 2014). In general, however, CMS studies
that report a decrease in sucrose intake or preference do also report
a loss of body weight (or a lower rate of body weight gain), even
where the CMS regime excludes food and water deprivation (e.g.
Strekalova et al., 2011; Remus et al., 2015). Consequently, if CMS
fails to change behaviour in the sucrose test, relative loss of body
weight could be taken as an approximate proxy measure to inform
a decision about whether to increase the intensity or variety of the
CMS regime.
Another pointer to the importance of CMS intensity is a critical
role of the hypothalamus-pituitary-adrenal (HPA) axis. The
behavioural and physiological effects of CMS can be mimicked by
chronic exogenous administration of corticosterone (Goshen et al.,
2008; Gourley and Taylor, 2009; Kvarta et al., 2015), and blocked by
the glucocorticoid receptor antagonist mifepristone (Wu et al.,
2007), the corticosterone synthesis inhibitor metyrapone (Kvarta
et al., 2015) or adrenalectomy (Goshen et al., 2008; Chen et al.,
2016). These data strongly suggest that a chronically elevated
physiological stress response, probably in the form of corticoste-
rone spikes in response to the onset of each individual stressor
(Sapolsky et al., 1984; Magarinos and McEwen, 1995), is both
necessary and sufﬁcient for the behavioural effects of CMS e as
discussed in more detail in the accompanying paper (Willner, 2016)
and elsewhere (Willner et al., 2013).
4.3. The wider context
The wider context for the current study is the ongoing concern
about reproducibility in biomedical research (Academy of MedicalPlease cite this article in press as: Willner, P., Reliability of the chronic m
(2016), http://dx.doi.org/10.1016/j.ynstr.2016.08.001Sciences, 2015; Begley and Ioannidis, 2015; Steckler, 2015). This
concern is driven by empirical studies demonstrating widespread
failures to replicate published results. For example, failure rates of
75e90% were found for attempts within the pharmaceutical in-
dustry to replicate preclinical studies (Prinz et al., 2011; Begley and
Ellis, 2012); similarly, a failure rate of around two thirds was re-
ported for attempts to replicate experiments published in high
ranking psychology journals (Open Science Collaboration, 2015).
There has been extensive discussion of the reasons for this state of
affairs. Problems with the original data include observer bias in
non-blinded experiments, failure to repeat observations before
publishing them, lack of legitimate controls, small sample sizes, use
of inappropriate statistical tests, and selective publication of partial
data sets (Begley, 2013; Button et al., 2013). Failures of replication
often involve departures from the earlier protocol (Wahlsten, 2001;
Wahlsten et al., 2003; Gilbert et al., 2016), but precise replication of
experimental conditions may be of lesser importance than prob-
lems at source: for example, attempts to replicate published data in
the ﬁelds of oncology, women's health and cardiovascular diseases
found that some results were reproducible when using different
protocols, while for others inconsistencies were found even when
using an identical protocol (Prinz et al., 2011).
There is no clear consensus as towhat constitutes a reproducible
study because the inherent variability in biological systems means
there is no expectation that results will necessarily be precisely
replicated; rather, “the major conclusions that emerge from a sci-
entiﬁc report should… withstand close interrogation” (Begley and
Ioannidis, 2015). Steckler (2015) summarized this issue in the
following terms: “A robust ﬁnding should be detectable under a
variety of experimental conditions, making obsolete the require-
ment for exact, point-by-point reproduction. … (Most) replication
studies are in fact studies testing the robustness of reported ﬁnd-
ings, since it may be difﬁcult to exactly recapitulate all details and
conditions under which the original datawere produced. Moreover,
robust data could be considered more important as they can be
seen under varying conditions and may be biologically more
relevant.”
Considering the overwhelming extent to which respondents to
the present survey reported that they ﬁnd the CMS model works
reliably in their lab, and that every lab implements an idiosyncratic
variant of the procedure, the conclusion that CMS causes a decrease
in responsiveness to rewards and other depression-relevant
changes in rodent behaviour should now be considered a highly
robust ﬁnding. It might be of interest to conduct similar studies to
evaluate the extent to which other animal models of psychiatric
disorders are similarly robust.
4.4. Conclusions
This study has some signiﬁcant limitations. In addition to those
already discussed (the small size and diversity of the ‘less reliable’
sample of labs, the omission of labs that may have worked with the
CMS model but not published their data, and the use of ad hoc
measures to compare the severity of different stress regimes) are
the use of surveymethodology (which relies on opinion rather than
hard data), the focus on the most widely used measures of CMS-
induced anhedonia (to the exclusion of, for example, anxiety-like
effects of CMS), and no discussion of the effectiveness of antide-
pressant treatments to reverse CMS effects (a topic that was
touched on in the survey but in insufﬁcient detail to justify
reporting). Nevertheless, it is possible to draw two conclusions on
the basis of the survey data and the published literature. First, the
important take-home message is that the CMS model does appear
to be generally reliable within laboratories and robust across lab-
oratories; and the many published statements to the effect that theild stress model of depression: A user survey, Neurobiology of Stress
P. Willner / Neurobiology of Stress xxx (2016) 1e10 9procedure is unreliable are incorrect. Second, while the critical
features of the CMS procedure remain uncertain, success with using
themodel appears to depend on an interplay between (i) individual
differences in susceptibility to stress, both within and between
animal populations, (ii) the overall severity of the micro-stressors
applied, which need to be sufﬁcient intense to evoke a physiolog-
ical stress response and sufﬁciently variable to prevent habituation
to their repeated presentation, and (iii) good laboratory practices
(for tips, see Strekalova and Steinbusch, 2010; Papp, 2012; Nollet
et al., 2013), which are particularly important when the sucrose
test is used as the main outcome measure.
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